Pelthos Therapeutics

PTHS · NYSE American

$20.50+$0.24 (+1.18%)TodayMarket closed ·
Prev close $20.26

Who owns PTHS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 87.2% of PTHS’s shares.

  • Ligand Pharmaceuticals Incorporated43.1%
  • 3I Management LLC9.2%
  • Murchinson Ltd.8.0%
  • Ikarian Capital LLC7.4%
  • Next 6 largest institutions19.5%
  • All other shareholders12.8%
Top institutional holders of PTHS
HolderShares% of shares
Ligand Pharmaceuticals Incorporated1.50M43.10%
3I Management LLC318.93K9.16%
Murchinson Ltd.280.00K8.05%
Ikarian Capital LLC256.60K7.37%
AIGH Capital Management, LLC.248.42K7.14%
Boothbay Fund Management, LLC101.98K2.93%
Vanguard Capital Management, LLC97.13K2.79%
Balmoral Financial Group LLC82.07K2.36%
Worth Venture Partners, LLC80.67K2.32%
Friedberg (Ezra M)68.30K1.96%

Largest mutual fund holders

Top mutual fund holders of PTHS
HolderShares% of shares
Vanguard Total Stock Market Index Fund78.01K2.24%
Vanguard Extended Market Index Fund16.13K0.46%
Fidelity Extended Market Index Fund7.70K0.22%
iShares Micro-Cap ETF5.06K0.15%
Fidelity Total Market Index Fund2.05K0.06%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $999.98K (2 trades) and sold $141.15K (10 trades) of PTHS on the open market.

Latest PTHS insider transactions
InsiderTypeSharesValue
Friedberg Ezra MSale558$11.56K
Pauls MatthewSale786$16.51K
Greenleaf PeterSale797$16.87K
Friedberg Ezra MSale24$656
Friedberg Ezra MSale534$13.90K
Pauls MatthewSale94$2.57K
Pauls MatthewSale692$17.99K
Greenleaf PeterSale85$2.32K
Greenleaf PeterSale712$18.51K
Davis Todd CBuy503$14.45K

Short interest

Settled Sep 30, 2026

Shares short
104.57K
Days to cover
4.07
% of shares outstanding
3.00%
Average daily volume
25.69K
Change since last report
+11.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.